Summary:
Do you have red, dry, scaly patches on your body?
Alliance Research is conducting this study to evaluate the safety and effectiveness of a new, un-marketed (experimental) Desoximetasone Spray, 0.15% (Taro Pharmaceuticals U.S.A., Inc) compared to a placebo spray in subjects with moderate to severe atopic dermatitis.
Participants must be 6 years of age and older,
and must have moderate to severe atopic dermatitis.
You will receive $60.00 for each completed office visit. If you are unable to complete the study, if you voluntarily leave the study, if the study is stopped early, or if you are qualified but not chosen to participate, you will be paid an appropriate amount based on your extent of participation.